NETRIS Pharma Welcomes Eric Falcand as Independent Director to Its Board of Directors
NETRIS Pharma Receives Best Biotech Pitch Award at EIC and Johnson & Johnson Healthcare Investor Day (powered by Bpifrance – Euroquity)
NETRIS Pharma Announces FDA Orphan Drug Designation (ODD) for NP137 in Pancreatic Cancer Treatment
Polygon Therapeutics shares recent achievements and acceleration for a First In Human in 2025
